2019 Archived Press Releases

Keyword Search

Pacira Completes Acquisition of MyoScience, Advancing Leadership in Non-opioid Pain Management with FDA-approved ioveraº System 04/09/19

Pacira Pharmaceuticals to Present at the 18th Annual Needham Healthcare Conference 04/02/19

New Analysis Shows Enhanced Recovery Pathway Including EXPAREL Infiltration Facilitates Rapid Discharge, High Satisfaction, and Limited Opioid Use in Medicare Patients Undergoing Total Joint Replacement 03/13/19

Pacira to Acquire MyoScience, Adding FDA-approved ioveraº System for Non-opioid Pain Control 03/05/19

Pacira Reports Record Fourth Quarter and Full Year Revenues 02/28/19

Pacira to Report 2018 Financial Results on Thursday February 28, 2019 02/21/19

Pacira Expands EXPAREL Manufacturing Capacity to Meet Growing Demand 02/12/19

EXPAREL Achieves Statistically Significant Reductions in Opioid Consumption and Pain Scores in Cesarean Section Patients 01/16/19

Pacira Reports Preliminary 2018 Net EXPAREL® Sales of $331 Million 01/03/19

Pacira Pharmaceuticals to Present at the 37th Annual J.P. Morgan Healthcare Conference 01/02/19

• 2019
• 2018
• 2017
• 2016
• 2015